Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
Pharm Res ; 37(9): 174, 2020 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-32856172

RESUMEN

PURPOSE: To apply a simple and flexible manufacturing technique, two-photon polymerisation (2PP), to the fabrication of microneedle (MN) array templates with high precision and low cost in a short time. METHODS: Seven different MN array templates were produced by 2PP 3D printing, varying needle height (900-1300 µm), shape (conical, pyramidal, cross-shaped and with pedestal), base width (300-500 µm) and interspacing (100-500 µm). Silicone MN array moulds were fabricated from these templates and used to produce dissolving and hydrogel-forming MN arrays. These polymeric MN arrays were evaluated for their insertion in skin models and their ability to deliver model drugs (cabotegravir sodium and ibuprofen sodium) to viable layers of the skin (ex vivo and in vitro) for subsequent controlled release and/or absorption. RESULTS: The various templates obtained with 2PP 3D printing allowed the reproducible fabrication of multiple MN array moulds. The polymeric MN arrays produced were efficiently inserted into two different skin models, with sharp conical and pyramidal needles showing the highest insertion depth values (64-90% of needle height). These results correlated generally with ex vivo and in vitro drug delivery results, where the same designs showed higher drug delivery rates after 24 h of application. CONCLUSION: This work highlights the benefits of using 2PP 3D printing to prototype variable MN array designs in a simple and reproducible manner, for their application in drug delivery.


Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Impresión Tridimensional/instrumentación , Piel/metabolismo , Administración Cutánea , Animales , Hidrogeles , Microinyecciones/instrumentación , Modelos Biológicos , Agujas , Polimerizacion , Polímeros/química , Porcinos
2.
Sci Rep ; 11(1): 23141, 2021 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-34848732

RESUMEN

Two sections of heat-treated (HT) and non-heat-treated (NHT) Cable-in-Conduit Conductor (CICC) of a design similar to the ITER tokomak have been imaged using very high energy X-ray tomography at the ESRF beamline ID19. The sample images were collected at four temperatures down to 77 K. These results showed a greater degree of movement, bundle distortion and touching strands in the NHT sample. The HT sample showed non-linear movements with temperature especially close to 77 K; increasing non-circularity of the superconducting fibre bundles towards the periphery of the CICC, and touching bundles throughout the CICC. The images have highlighted where future design might improve potential weakness, in particular at the outer perimeters of the conductor and the individual sub-cable, 'petal' wraps.

3.
Chem Res Toxicol ; 22(7): 1239-45, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19408964

RESUMEN

As a step toward exploring a targeted metabolomics approach to personalized warfarin (Coumadin) therapy, we developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method capable of quantifying specific enantiomeric (R and S) contributions of warfarin (WAR) and the corresponding hydroxywarfarins (OH-WAR) and glucuronides (-GLUC) generated by cytochrome P450s (CYP) and UDP-glucuronosyltransferases (UGTs), respectively. Evaluation of quality control samples and three commercially available human samples showed that our analytical approach has the ability to measure 24 unique WAR metabolites in human urine. Evaluation of the human data also provides new insights for evaluating WAR toxicity and begins characterizing important UGT metabolic pathways responsible for WAR detoxification. Data revealed the significance of specific metabolites among patients and the corresponding enzymatic capacity to generate these compounds, including the first report of direct WAR glucuronidation. On the basis of total OH-WAR levels, (S)-7-OH-WAR was the predominant metabolite indicating the significance of CYP2C9 in WAR metabolism, although other CYP2C enzymes also contributed to clearance of this isomer. (R)-WAR hydroxylation to OH-WARs was more diverse among the patients as reflected in varying contributions of CYP1A2 and multiple CYP2C enzymes. There was wide variation in the glucuronidation of WAR and the OH-WARs with respect to the compounds and patients. 6- and 7-OH-WAR were primarily (>70%) excreted as glucuronides unlike 4'-OH-WAR and 8-OH-WAR. For all patients, UGT1A1 is likely responsible for 6-O-GLUC production, although UGT1A10 may also contribute in one patient. 7-O-GLUC levels reflected contributions from potentially five different UGT1A enzymes. In all cases, WAR, 4'-OH-WAR, 8-OH-WAR, and the corresponding glucuronides were minor metabolites with respect to the others. Taken together, these data suggest that both P450 and UGT reactions contribute to the generation of excretable products in human urine, thereby generating complex metabolic networks.


Asunto(s)
Anticoagulantes/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Glucuronosiltransferasa/metabolismo , Warfarina/metabolismo , Anticoagulantes/toxicidad , Anticoagulantes/orina , Cromatografía Líquida de Alta Presión , Humanos , Metabolómica , Estereoisomerismo , Espectrometría de Masas en Tándem , Warfarina/toxicidad , Warfarina/orina
4.
J Pharmacol Exp Ther ; 324(1): 139-48, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17921187

RESUMEN

Our understanding of human phase II metabolic pathways which facilitate detoxification and excretion of warfarin (Coumadin) is limited. The goal of this study was to test the hypothesis that there are specific human hepatic and extrahepatic UDP-glucuronosyltransferase (UGT) isozymes, which are responsible for conjugating warfarin and hydroxylated metabolites of warfarin. Glucuronidation activity of human liver microsomes (HLMs) and eight human recombinant UGTs toward (R)- and (S)-warfarin, racemic warfarin, and major cytochrome P450 metabolites of warfarin (4'-, 6-, 7-, 8-, and 10-hydroxywarfarin) has been assessed. HLMs, UGT1A1, 1A8, 1A9, and 1A10 showed glucuronidation activity toward 4'-, 6-, 7-, and/or 8-hydroxywarfarin with K(m) values ranging from 59 to 480 microM and V(max) values ranging from 0.03 to 0.78 microM/min/mg protein. Tandem mass spectrometry studies and structure comparisons suggested glucuronidation was occurring at the C4'-, C6-, C7-, and C8-positions. Of the hepatic UGT isozymes tested, UGT1A9 exclusively metabolized 8-hydroxywarfarin, whereas UGT1A1 metabolized 6-, 7-, and 8-hydroxywarfarin. Studies with extrahepatic UGT isoforms showed that UGT1A8 metabolized 7- and 8-hydroxywarfarin and that UGT1A10 glucuronidated 4'-, 6-, 7-, and 8-hydroxywarfarin. UGT1A4, 1A6, 1A7, and 2B7 did not have activity with any substrate, and none of the UGT isozymes evaluated catalyzed reactions with (R)- and (S)-warfarin, racemic warfarin, or 10-hydroxywarfarin. This is the first study identifying and characterizing specific human UGT isozymes, which glucuronidate major cytochrome P450 metabolites of warfarin with similar metabolic rates known to be associated with warfarin metabolism. Continued characterization of these pathways may enhance our ability to reduce life-threatening and costly complications associated with warfarin therapy.


Asunto(s)
Anticoagulantes/metabolismo , Glucurónidos/metabolismo , Glucuronosiltransferasa/metabolismo , Microsomas Hepáticos/metabolismo , Warfarina/metabolismo , Hidrocarburo de Aril Hidroxilasas/genética , Hidrocarburo de Aril Hidroxilasas/metabolismo , Citocromo P-450 CYP2C9 , Glucuronosiltransferasa/genética , Humanos , Hidroxilación , Cinética , Proteínas Recombinantes/metabolismo , Warfarina/análogos & derivados
5.
Philos Trans A Math Phys Eng Sci ; 370(1980): 5567-612, 2012 Dec 13.
Artículo en Inglés | MEDLINE | ID: mdl-23129713

RESUMEN

Much progress has been made in the UK in characterizing the internal structures of major physiographic features in the oceans and in developing understanding of the geological processes that have created or shaped them. UK researchers have authored articles of high impact in all areas described here. In contrast to terrestrial geoscience, however, there have been few instrumented observations made of active processes by UK scientists. This is an area that could be developed over the next decades in the UK. Research on active processes has the potential ability to engage the wider public: Some active processes present significant geo-hazards to populations and offshore infrastructure that require monitoring and there could be commercial applications of technological developments needed for science. Some of the suggestions could involve studies in shallow coastal waters where ship costs are much reduced, addressing tighter funding constraints over the near term. The possibilities of measuring aspects of volcanic eruptions, flowing lava, turbidity currents and mass movements (landslides) are discussed. A further area of potential development is in greater collaboration between the ocean sciences. For example, it is well known in terrestrial geomorphology that biological agents are important in modulating erosion and the transport of sediments, ultimately affecting the shape of the Earth's surface in various ways. The analogous effect of biology on large-scale geomorphology in the oceans is also known but remains poorly quantified. Physical oceanographic models are becoming increasingly accurate and could be used to study further the patterns of erosion, particle transport and deposition in the oceans. Marine geological and geophysical data could in turn be useful for further verification of such models. Adapting them to conditions of past oceans could address the shorter-period movements, such as due to internal waves and tides, which have been barely addressed in palaeoceanography.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA